CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 252 filers reported holding CONMED CORP in Q2 2021. The put-call ratio across all filers is 8.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $211 | +205.8% | 2,033 | +158.7% | 0.00% | – |
| Q4 2022 | $69 | -99.9% | 786 | 0.0% | 0.00% | – |
| Q3 2022 | $63,000 | -16.0% | 786 | 0.0% | 0.00% | – |
| Q2 2022 | $75,000 | -98.9% | 786 | -98.3% | 0.00% | -100.0% |
| Q1 2022 | $6,925,000 | -14.0% | 46,620 | -17.9% | 0.01% | -11.1% |
| Q4 2021 | $8,052,000 | +17031.9% | 56,802 | +15634.6% | 0.01% | – |
| Q3 2021 | $47,000 | -89.7% | 361 | -89.6% | 0.00% | -100.0% |
| Q1 2021 | $455,000 | -49.1% | 3,485 | -56.4% | 0.00% | 0.0% |
| Q4 2020 | $894,000 | +3338.5% | 7,991 | +2299.7% | 0.00% | – |
| Q3 2020 | $26,000 | -40.9% | 333 | -45.9% | 0.00% | – |
| Q2 2020 | $44,000 | -96.4% | 615 | -97.2% | 0.00% | -100.0% |
| Q1 2020 | $1,238,000 | +33.8% | 21,630 | +161.2% | 0.00% | +100.0% |
| Q4 2019 | $925,000 | +44.5% | 8,280 | +24.2% | 0.00% | 0.0% |
| Q3 2019 | $640,000 | +63.3% | 6,665 | +45.2% | 0.00% | 0.0% |
| Q2 2019 | $392,000 | – | 4,591 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 190,000 | $24,858,000 | 3.57% |
| Ranger Investment Management | 253,789 | $33,203,000 | 1.77% |
| EARNEST PARTNERS LLC | 1,603,130 | $209,737,000 | 1.28% |
| Penn Capital Management Company, LLC | 92,086 | $12,048,000 | 1.22% |
| Champlain Investment Partners, LLC | 1,492,419 | $195,253,000 | 0.94% |
| MOODY ALDRICH PARTNERS LLC | 53,257 | $6,968,000 | 0.88% |
| Hood River Capital Management LLC | 215,384 | $28,179,000 | 0.87% |
| OAK RIDGE INVESTMENTS LLC | 71,880 | $9,404,000 | 0.83% |
| WAFRA INC. | 138,542 | $18,125,000 | 0.66% |
| EPIQ PARTNERS, LLC | 10,463 | $1,369,000 | 0.63% |